Want to ensure your QRM will keep you compliant — and competitive — moving forward?

It’s not easy given that understanding the principles of quality risk management (QRM) and how to apply them are not well-described in the regulations, despite ICH Q9 having been adopted by the FDA in 2006.

Meanwhile, EU GMP Annex 1 Manufacture of Sterile Medicinal Products, currently in draft, may be finalized in late 2021 and will increase risk management and risk assessment to ensure contamination control.

Add to these the fact that many organizations are making or have recently made decisions about how to maintain production levels given the pandemic and this webinar is a tremendous opportunity to explore the risks and apply risk-based decisionmaking to fully understand the long-term impacts.

Amanda McFarland, a QRM and microbiology senior consultant with ValSource, Inc., will clarify the regulations relative to risk management and how to apply the principles of QRM to do just that.

Webinar Takeaways:

• Best practices related to QRM program development and execution, including process, people and documentation
• Ways to integrate QRM into your quality systems such as change control and investigations and how integration can benefit your organization
• The PIC/S Aide-Memoire on QRM and how you can prepare for a QRM program inspection
• How to evaluate the risk management tools available to you to meet regulatory requirements, such as PHA, REM, HACCP and FMEA
• Recognize the critical QRM regulations that apply to pharma such as ICH 9, ICH Q10, ISO 14644 and Annex 1

 

While risk is everywhere, and ever-increasing, this webinar will enable you to use the principles of QRM and risk-based decisionmaking to ensure compliance going forward.